Cognizant Adds Several New Healthcare Clients Based on Proven HIPAA Capabilities.

Business/Technology Editors

TEANECK, N.J.--(BUSINESS WIRE)--April 30, 2002

Cognizant's Investment in End-to-End HIPAA Solutions Including

Training Offerings, Tools, and Methodologies is Paying Off

Cognizant Technology Solutions Corp. (Nasdaq: CTSH), a leading provider of custom software development, integration and application outsourcing services, and a leader in providing HIPAA solutions, today announced that it has recently added four new HIPAA clients including two large Blue-affiliated plans.

These companies recognize Cognizant as a long-term partner with the right business model, industry knowledge and technical expertise to consistently deliver outstanding results that enhance their growth prospects and increase their efficiency.

"Managing HIPAA with day-to-day business and other initiatives can be very complex and problematic, but with Cognizant's HIPAA-specific project-planning and remediation services, we are on our way to achieving compliance and all of the benefits that go along with it, including greater ROI, and smoother and more efficient processing and communications," said Edward P Syron Sr. Director, Operational Performance Improvement, at a leading healthcare company in the Northeast, where Cognizant is in the late stages of a comprehensive end-to-end HIPAA remediation project.

Cognizant's HIPAA solutions include online training, gap analysis, remediation planning, and implementation and post implementation support. Cognizant uses various custom tools such as HIPAA@net, a web based training module, EDI Compliance Monitor, a transaction testing tool, and Regulation Interpretation and Assessment Tool (RIAT) an assessment kit. Government mandated HIPAA regulations require compliance by October 2003 for transactions.

"For two years, Cognizant has offered complete end-to-end HIPAA solutions and has a proprietary set of proven tools and methodologies," said Kumar Mahadeva, Chairman and CEO of Cognizant. "Our HIPAA methodology, HIPAA program management expertise, and tool suite ensure a smooth transition for health care organizations into the HIPAA-compliant era."

HIPAA is one of Cognizant's comprehensive suites of focused healthcare solutions. Cognizant's healthcare solutions combine deep industry knowledge, proven methodologies and proprietary tools that enable IT-intensive healthcare organizations to conquer the unique challenges of their industry and compete on a higher level. Cognizant helps cut customers operating costs, boost efficiency, speed and responsiveness, meet compliance deadlines, and develop new market opportunities. Healthcare clients comprise 27% of Cognizant's revenues.

About Cognizant Technology Solutions

Cognizant Technology Solutions (Nasdaq: CTSH) is a leading provider of custom software development, integration and management services that link e-business with core information systems for companies worldwide. Cognizant operates under a high quality, high value onsite/offshore model that enables better, faster and more cost effective development and deployment of large-scale systems across a wide range of transaction intensive business needs.

Its 3,800 employees are committed to partnerships that sustain long-term, proven value in order to win in today's global marketplace. Cognizant was listed as one of the "Best Small Companies in America," by Forbes and as the top solutions provider and one of the top 200 Hot Companies by Business Week. Cognizant has been assessed at SEI/CMM Level 5, the highest possible rating.

Certain statements contained herein, including statements regarding the development of the Company's services, markets and future demand for the Company's services, projections on future growth potential, and other statements regarding matters that are not historical facts, are forward-looking statements (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include risks and uncertainties; consequently, actual results may differ materially from those expressed or implied thereby. Factors that could cause actual results to differ materially include, but are not limited to, variability of quarterly operating results, reliance on large projects, concentration of revenue, ability to attract and retain professional staff, dependence on key personnel, ability to manage growth effectively, risks associated with rapid technological advances, risks associated with possible acquisitions, risks associated with the Company's strategic partnerships, various project-associated risks, substantial competition, general economic conditions, risks associated with intellectual property rights, risks associated with international operations and other risk factors listed from time to time in the Company's filings and reports with the Securities and Exchange Commission.